Page 13 - 80_01

Cancer
cells
need
MTH1...

REFERENCIAS

1.
Gad,
H.;
Koolmeister,
T.;
Jemth,
A.-­-S.;
Eshtad,
S.;
Jacques,
S.
A.;
Ström,
C.
E.;

Svensson,
L.
M.;

Schultz,
N.;
Lundbäck,
T.;
Einarsdottir,
B.
O.;
Saleh,
A.;
Göktürk,
C.;
Baranczewski,
P.;

Svensson,
R.;
Berntsson,
R.
P.-­-A.;
Gustafsson,
R.;
Strömberg,
K.;
Sanjiv,
K.;
Jacques-­-
Cordonnier,
M.-­-C.;
Desroses,
M.;
Gustavsson,
A.-­-L.;
Olofsson,
R.;
Johansson,
F.;
Homan,
E.
J.;

Loseva,
O.;
Bräutigam,
L.;
Johansson,
L.;
Höglund,
A.;
Hagenkort,
A.;
Pham,
T.;
Altun,
M.;

Gaugaz,
F.
Z.;
Vikingsson,
S.;
Evers,
B.;
Henriksson,
M.;
Vallin,
K.
S.
A.;
Wallner,
O.
A.;

Hammarström,
L.
G.
J.;
Wiita,
E.;
Almlöf,
I.;
Kalderén,
C.;
Axelsson,
H.;
Djureinovic,
T.;

Carreras
Puigvert,
J.;
Häggblad,
M.;
Jeppsson,
F.;
Martens,
U.;
Lundin,
C.;
Lundgren,
B.;

Granelli,
I.;
Jenmalm
Jensen,
A.;
Artursson,
P.;
Nilsson,
J.
A.;
Stenmark,
P.;
Scobie,
M.;

Berglund,
U.
W.;
Helleday,
T.;
(2014)
“MTH1
inhibition
eradicates
cancer
by
preventing

sanitation
of
the
dNTP
pool”;
Nature,
doi:
10.1038/nature13181.

2.
Kilian
V.
M.
Huber,
Eidarus
Salah,
Branka
Radic,
Manuela
Gridling,
Jonathan
M.
Elkins,

Alexey
Stukalov,
Ann-­-Sofie
Jemth,
Camilla
Göktürk,
Kumar
Sanjiv,
Kia
Strömberg,
Therese

Pham,
Ulrika
Warpman
Berglund,
Jacques
Colinge,
Keiryn
L.
Bennett,
Joanna
I.
Loizou,

Thomas
Helleday,
Stefan
Knapp
&
Giulio
Superti-­-Furga;
(2014)
“Stereospecific
targeting

of
MTH1
by
(S)-­-crizotinib
as
an
anticancer
strategy”;
Nature,
doi:10.1038/nature13194.

3.
Streib,
M.;
Kräling,
K.;
Richter,
K.;
Xie,
X.;
Steuber,
H.;
Meggers,
E.;
(2014)
“An
Organometallic

Inhibitor
for
the
Human
Repair
Enzyme
7,8-­-Dihydro-­-8-­-oxoguanosine
Triphosphatase”,

Angew.
Chem.
Int.
Ed.,
53,
305-­-309.

4.
Halliwell,
B.;
Gutteridge,
J.
M.
C.;
(1999)
“Free
Radicals
in
Biology
and
Medicine”,
3rd

Edition,
Oxford
University
Press.

5.
Cheng,
K.
C.;
Cahill,
D.
S.;
Kasai,
H.;
Nishimura,
S.;
Loeb,
L.
A.;

(1992)
“8-­-Hydroxyguanine,
an

Abundant
Form
of
Oxidative
DNA
Damage
Causes
G?T
and
C?A
substitutions”,
J.
Biol.

Chem.,
267,
166-­-172.

6.
Nakabeppu,
Y.;
Kajitani,
K.;
Sakamoto,
K.;
Yamaguchi,
H.;
Tsuchimoto,
D.;
(2006)

“MTH1,
an

oxidized
purine
nucleoside
triphosphatase,
prevents
the
cytotoxicity
and
neurotoxicity
of

oxidized
purine
nucleotides”,
DNA
Repair
(Amst),
5,
761-­-772.

7.
Svensson,
L.
M.;
Jemth,
A.-­-S.;
Desroses,
M.;
Loseva,
O.;
Helleday,
T.;
Högbom,
M.;
Stenmark,

P.;

(2011)

“Crystal
structure
of
human
MTH1
and
the
8-­-oxo-­-dGMP
product
complex”,

FEBS
Lett.,
585,
2617-­-2621.

8.
Nakabeppu,
Y.;
Tsuchimoto,
D.;
Furuichi,
M.;
Sakumi,
K.;
(2004)
“The
defense
mechanisms
in

mammalian
cells
against
oxidative
damage
in
nucleic
acids
and
their
involvement
in
the

suppression
of
mutagenesis
and
cell
death”,
Free
Radic.
Res.
2004,
38,
423-­-429
(Review).

9.
Nakabeppu,
Y.;
Tsuchimoto,
D.;
Ichinoe,
A.;
Ohno,
M.;
Ide,
Y.;
Hirano,
S.;
Yoshimura,
D.;

Tominaga,
Y.;
Furuichi,
M.;
Sakumi,
K.;
(2004)

“Biological
significance
of
the
defense

mechanisms
against
oxidative
damage
in
nucleic
acids
caused
by
reactive
oxygen
species:

from
mitochondria
to
nuclei.”
Ann.
N.
Y.
Acad.
Sci.
1011,101-­-111.

10.
Nakabeppu,
Y.;
Tsuchimoto,
D.;
Yamaguchi,
H.;
Sakumi,
K.;
(2007)
“Oxidative
damage
in

nucleic
acids
and
Parkinson's
disease.”,
J.
Neurosci.
Res.,
85,
919-­-934.
(Review).

13